Navigation Links
Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
Date:11/30/2007

ns in blood pressure than either drug alone. This, along with its favorable side-effect profile, should make AZOR an attractive treatment option for patients whose blood pressure does not respond to either component drug in isolation. U.S. approval was granted in September 2007.

While the reason for menopause remains unknown, KV Pharmaceutical believes EvaMist, which takes the third spot on the list, may offer significant advantages to women experiencing menopause. This product is a small, easy-to- use hand-held applicator that delivers a pre-set metered dose via the skin, releasing estradoil into the bloodstream over 24 hours. EvaMist gained FDA approval in July 2007.

The first of two potential treatments for cancer on the list of notable drugs gaining approval this quarter is Yondelis, developed by PharmaMar for patients who have not responded to previous regimens in their treatment of soft tissue sarcoma. Yondelis is the first approved product from PharmaMar, a Spanish biotech specializing in cancer drugs derived from marine organisms and has Orphan Drug status in both the EU and U.S., securing extended protection against generic competition.

The second approval win for Novartis this quarter, Tasigna, is an orally available inhibitor of Bcr-Abl, c-Kit, PDGF-R and related receptor tyrosine kinases for the potential treatment of various types of leukemia. Though the drug has been approved only in Switzerland for chronic myeloid leukemia, it is awaiting approval in the U.S. and Japan and has been recommended for approval across the EU.

Following are the top five drugs in each category of phase changes:

The Five Most Promising Drugs Entering Phase III Trials

* bevasiranib sodium, (Wet AMD), Opko

* recombinant active glucocerebrosidase, (Gaucher's disease), Protalix

* odanacatib, (osteoporosis), Merck & Co

* laquinimod, (multiple sclerosis), Active Biotech/Teva

* elesclomol, (solid tumors), Synta
'/>"/>

SOURCE Thomson Scientific
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too
10. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
11. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... 2013 Anant Goel, CEO at RKNet ... empower children and adults with skills of the 21st Century ... form the foundation for success in the new millennium. Everyone ... access to technology does not automatically make us the master ... work, businesses, and life." , The following ...
(Date:6/20/2013)... TX (PRWEB) June 20, 2013 ... maintained a wide range of outpatient and inpatient mental ... issues, including those who are children. As a facility ... explains that it is critical to diagnose mental health ... However, according to a recent article from ...
(Date:6/20/2013)... NJ (PRWEB) June 20, 2013 As ... is volunteer assistance. Keeping volunteers motivated in a non-profit ... Kars4Kids , a the nation’s leading car donation charity ... network of over 1,000 individuals, has announced the best ... not only physically present, but mentally engaged as well. ...
(Date:6/20/2013)... Businesses which are failing to be savvy where ... in the tidal wave of competition, warns Australia's leading business ... 50 Tips Collected from the Top Blogs is available ... to listen to the social media pros. This is because ... since its onset and they, more than most PR pros ...
(Date:6/20/2013)... Dorset (PRWEB) June 20, 2013 Millions ... and more serious medical conditions because they do not ... Eludril mouthwash and Elgydium toothpaste. , Seven million Britons ... it 48 hours between brushes, latest data from the ... cent of people polled by the BDHF also admitted ...
Breaking Medicine News(10 mins):Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 2Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 3Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 2Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 3Health News:Kars4kids Announces Tips on How to Keep Non-profit Volunteers Engaged, Passionate and Active 2Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 2Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 3Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3
... restriction seems to be the key to extend the ... ,Researchers from Harvard Medical School, Boston and University of ... lifespan via Sir2 gene. According to the study published ... and Drosophila lacking the Sir2 gene do not live ...
... Research and Lviv Regional Oncology center//, Ukraine has developed ... detection of breast and ovarian cancer. ,However, they ... "Attempts to find a single reliable early protein, or ... been very successful," says LICR's Serhiy Souchelnytskyi, senior author ...
... of Mayo Clinic have found the cause of chronic sinus ... infected and not the nasal and sinus tissue. The findings ... Allergy and Clinical Immunology. ,Researchers fro the study report ... the diseased airway tissue is not valid anymore, as their ...
... time and again thought ways to deter their toddlers// from ... channels, but how many are right for viewing by children. ... adding parents is a scientific that can help them justify ... educational purposes, it harms the cognitive development. ,A ...
... investigating the mysterious death of a woman whose entire body ... ears in an ordeal that started with a simple fever, ... disbelief, the family of June Wong, 26, is demanding answers. ... , ,Wong is suspected of having Stevens-Johnson Syndrome, a severe ...
... want to know answers to everything. This gains special// importance ... often have we questioned the diseases that make our precious ... ,Researchers in a breakthrough have unraveled the mystery surrounding heart ... failure, the heart uses too much fatty acid and not ...
Cached Medicine News:Health News:Genes to Extend Longevity Discovered 2Health News:Molecular markers for early diagnosis of breast and ovarian cancer 2Health News:Chronic Sinusitis May Be Related To Nasal Mucus 2Health News:Stop Watching TV: Toddler Development Affected 2
(Date:6/19/2013)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... of Medicine ( NEJM ) published results online ... Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients with ... (SLL). Ibrutinib was shown to be safe and effective ... patients who were at high-risk due to factors such ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Germany , is providing a deeper ... of developing type 1 diabetes (T1D), highlighting the importance ... The study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... in The Journal of the American Medical Association ...
(Date:6/19/2013)... June 19, 2013  Finesse Solutions, Inc, a ... sciences process applications, announced the launch of its ... cell culture and fermentation.  The 3L glass vessels ... of Finesse bioreactors and are designed to optimize ... are fully compatible with all Finesse G3Lab controllers, ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... Inc.,(Nasdaq: NVAX ) today announced that the Company ... the Phase I/IIa human clinical,trial of Novavax,s H5N1 pandemic ... August 26, 2008., The call will be hosted ... and other members of senior management, including,Chief Medical Officer, ...
... Johnson & Johnson Pharmaceutical,Research & Development, ... Food,and Drug Administration (FDA) requires additional information ... Application (NDA) for DORIBAX(TM),(doripenem for injection) for ... nosocomial pneumonia (NP), including ventilator-associated,pneumonia (VAP)., ...
Cached Medicine Technology:Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 3FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 4FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 5
... Oval-8 Ring Splints provide finger stability ... acute injuries, hypermobility, and loss of control ... splints are made from translucent, neutral-tone plastic ... The 3-point pressure design makes them the ...
... controlled stretch knee support that helps reduce ... range of motion. The medial and ... and help to keep the elastic material ... is an excellent support for post-surgical recovery. ...
... laminated to breathable foam. Three piece design ... straps with loop closures. Lightweight rigid posterior ... ,Available with optional hot and cold ... defeat the pain cycle by providing cold ...
... of the outstanding features of our Neomax ... Molding Technology. , This manufacturing process allows ... controls the bunching and irritation in the ... wearer. , ,Colors available: Blue, ...
Medicine Products: